Jubilant Generics Limited Valacyclovir Export Data — India (DGFT 2022–2026)

Name: Jubilant Generics Limited Valacyclovir Export Records India — #7 Exporter, 5 Shipments, $250.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Valacyclovir

India Pharmaceutical Trade Intelligence

$93.2M113 Suppliers70 CountriesHS 30049099

ExportsIndia → UNITED STATES87.2%India → CANADA4.0%

ImportsUNITED STATES → India$11.1K GERMANY → India$3.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Jubilant Generics Limited — Valacyclovir Exporter #7 | $537.8K Trade Value | TransData Nexus | TransData Nexus

Jubilant Generics Limited — Valacyclovir Exporter Profile

Indian Pharmaceutical Exporter · #7 for Valacyclovir · $537.8K export value · DGFT Verified

Jubilant Generics Limited is the #7 Indian exporter of Valacyclovir with $537.8K in export value and 5 verified shipments. Jubilant Generics Limited holds a 0.3% market share in Valacyclovir exports across 2 countries. The company exports 6 pharmaceutical products worth $23.9M across 4 therapeutic categories.

Jubilant Generics Limited — Valacyclovir Export Profile: Buyers & Destinations

Jubilant Generics Limited Valacyclovir export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Valacyclovir?

Country	Value	Shipments	Share
UNITED STATES	$14.3M	285	63.7%
CANADA	$2.4M	48	10.7%
SWEDEN	$1.9M	38	8.3%
TAIWAN	$1.4M	27	6.0%

Who Are the Top Buyers of Valacyclovir from India?

Buyer	Country	Value	Orders
XXMBEXXPHAXXACEXXICAXX IXX	UNITED STATES	$2.5M	49
SIVEM PHARMACEUTICALS	UNITED STATES	$1.6M	31
JAMP PHARMA CORPORATION	CANADA	$1.3M	37
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.1M	23
CAMBER PHARMACEUTICALS INC	UNITED STATES	$1.1M	23
MYLAN PHARMACEUTICALS INC	UNITED STATES	$1.1M	21
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$550.0K	11
CAMBER PHARMACEUTICALS INC.	UNITED STATES	$350.0K	7
NORTHSTAR HEALTHCARE	UNITED STATES	$300.0K	6
MYLAN PHARMACEUTICALS ULC	CANADA	$200.0K	4

India's Valacyclovir is purchased by 197 buyers worldwide. The top buyer is XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES), followed by SIVEM PHARMACEUTICALS and JAMP PHARMA CORPORATION.

How Does Jubilant Generics Limited Compare to Nearest Valacyclovir Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	CIPLA LIMITED	$455.8K	15	2	$30.4K
8	JUBILANT GENERICS LTD	$287.8K	6	1	$48.0K
7	JUBILANT GENERICS LIMITED ★	$250.0K	5	2	$50.0K
10	SAVA HEALTHCARE LIMITED	$243.8K	157	2	$1.6K
5	AUROBINDO PHARMA LIMITED	$200.0K	4	2	$50.0K

Jubilant Generics Limited ranks #7 among 113 Indian Valacyclovir exporters. Average shipment value of $50.0K compared to the market average of $187.0K. The closest competitors by value are CIPLA LIMITED and JUBILANT GENERICS LTD.

Which Indian Ports Ship Valacyclovir Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	571	22.5%
SAHAR AIR CARGO ACC (INBOM4)	495	19.5%
SAHAR AIR	366	14.4%
DELHI AIR	311	12.3%
Delhi Air	110	4.3%
Bombay Air	107	4.2%
BANGALORE ICD (INWFD6)	60	2.4%
NHAVA SHEVA SEA (INNSA1)	54	2.1%

Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Valacyclovir Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jubilant Generics. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. These disruptions have particularly impacted exports to the Middle East, a key market for Indian pharmaceuticals. (fortuneindia.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters to capture a larger share of the U.S. market. However, recent U.S. tariffs on imports, including pharmaceuticals, pose a risk to this opportunity. The Federation of Indian Export Organisations highlighted that these tariffs could affect nearly 55% of India's exports to the U.S., potentially leading to the loss of longstanding clients. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must invest in serialization and traceability systems to meet these stringent regulations, ensuring continued access to the EU market.

Jubilant Generics Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Jubilant Generics. The company's Roorkee facility's VAI classification by the USFDA in 2024 reflects its adherence to current good manufacturing practices. (business-standard.com) However, the Indian pharmaceutical industry faces ongoing scrutiny regarding quality and compliance. In 2023, the USFDA conducted over 200 inspections in India, with plans to increase this number in 2024, underscoring the need for continuous quality assurance. (fact.net.in)

Additionally, the company has faced legal challenges concerning intellectual property. In March 2025, a court in Uttar Pradesh restrained Jamp Pharma from using Jubilant Generics' confidential data, granting an injunction against copyright infringement. (scconline.com) This case highlights the importance of safeguarding proprietary information in the competitive pharmaceutical landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Valacyclovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Jubilant Generics Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 70+ countries, 197+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Valacyclovir

Valacyclovir

Jubilant Generics Limited — Valacyclovir Exporter Profile

Jubilant Generics Limited — Valacyclovir Export Profile: Buyers & Destinations

Where Does India Export Valacyclovir?

Who Are the Top Buyers of Valacyclovir from India?

What Is India's Total Valacyclovir Export Value and How Much Does Jubilant Generics Limited Contribute?

What Is the Average Shipment Value for Jubilant Generics Limited's Valacyclovir Exports?

How Does Jubilant Generics Limited Compare to Other Indian Valacyclovir Exporters?

Regulatory Requirements: Exporting Valacyclovir to Key Markets

United States — FDA

Canada — HC

How Does Jubilant Generics Limited Compare to Nearest Valacyclovir Exporters?

Which Indian Ports Ship Valacyclovir Exports?

Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Valacyclovir Exports

Jubilant Generics Limited — Regulatory Compliance & Quality Standards

About Jubilant Generics Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Valacyclovir Export Data from Jubilant Generics Limited

Valacyclovir Stats

Company Overview

Top Products by Jubilant Generics Limited

Related Analysis

Need Detailed Export Data?

Data Source